Target intelligence / Profile preview

Immune response mediators

Molecular classification
Cytokine, Chemokine, Interleukin, Interferon, Acute phase reactant, Colony-stimulating factor, Other (category, not a single molecule or target)
01

Overview

Immune response mediators describes a *class of diverse signaling molecules* secreted by cells of the immune system for communication and regulation of immune responses. The primary members are cytokines—including interleukins, interferons, chemokines, and colony-stimulating factors—which *regulate inflammation, cell recruitment, cell proliferation, and pathogen clearance*. These mediators are essential for orchestrating both innate and adaptive immunity as well as maintaining immune homeostasis, but their dysregulation is implicated in a wide range of acute and chronic diseases. The entry "Immune response mediators" does not represent a single analyzable molecular entity and is *not suitable as a canonical drug target*, as it groups together a complex functional category containing many distinct, well-defined therapeutic targets.

Other names
CytokinesInterleukinsInterferonsChemokinesImmune modulatorsImmune mediators
02

Mechanism of action

Blockade of cytokine/receptor interaction (e.g., anti-TNF, anti-IL-6); Cytokine receptor antagonism; Neutralization of circulating cytokines; Immune modulation (stimulation or inhibition of immune cell function); Inhibition of cytokine signaling pathways (e.g., JAK/STAT pathway inhibitors)

03

Biological functions

Signal transductionImmune responseCell proliferationCell migrationInflammation modulationInduction of apoptosisHematopoiesis
04

Disease associations

InflammationCancerInfectionAutoimmune disordersAllergic diseaseCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Increased risk of infection due to immunosuppressionCytokine release syndromeAutoimmune reactionsHypersensitivity reactionsOrgan toxicity (e.g., liver, hematologic)
06

Interacting drugs

Anti-cytokine monoclonal antibodies (infliximab, adalimumab)

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)Interferon gamma (IFN-γ)ESR (erythrocyte sedimentation rate)Procalcitonin

Beyond the preview

Go deeper on Immune response mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune response mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call